TREM2 and Alzheimer disease: In contrast, one study discovered that the AD mouse model TREM2 knock-out (APPPS1; Trem2−/−) has decreased expression of the pro-inflammatory cytokines IL-1β and IL-6 and increased expression of anti-inflammatory markers associated with reduced Aβ and tau protein pathological alterations [22].